Results 21 to 30 of about 167,277 (295)

Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries [PDF]

open access: yes, 2012
The most common cause of severe diarrhea in infants and young children is rotavirus gastroenteritis (RVGE), which is associated with significant morbidity, healthcare resource use, and direct and indirect costs in industrialized nations.
Greg L. Plosker
core   +1 more source

Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype [PDF]

open access: yes, 2015
Seasonal epidemics caused by influenza A (H1 and H3 subtypes) and B viruses are a major global health threat. The traditional, trivalent influenza vaccines have limited efficacy because of rapid antigenic evolution of the circulating viruses.
Citron, Michael   +6 more
core   +4 more sources

Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance [PDF]

open access: yes, 2012
SCOPUS: re.jinfo:eu-repo/semantics ...
Hanquet, Germaine, Vergison, Anne
core   +1 more source

bNAber: database of broadly neutralizing HIV antibodies. [PDF]

open access: yes, 2013
The discovery of broadly neutralizing antibodies (bNAbs) has provided an enormous impetus to the HIV vaccine research and to entire immunology. The bNAber database at http://bNAber.org provides open, user-friendly access to detailed data on the rapidly ...
Burton, Dennis R   +8 more
core   +4 more sources

Economic evaluation of HBV vaccination: a systematic review of recent publications (2000-2013). [PDF]

open access: yes, 2016
Aim: To conduct a systematic review of the economic evaluations (EE) of HBV vaccination, taking also into account the studies published in the new millennium. Methods: An extensive scientific literature review was conducted using two electronic medical
COLAMESTA, VITTORIA   +6 more
core   +1 more source

Exploring the potential public health benefits of universal influenza vaccine

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Background: Broadly protective, long-lasting universal influenza vaccines are under development in response to low-moderate seasonal vaccine effectiveness, frequent genetic changes in circulating viruses and extended turnaround for vaccine manufacture ...
Jay V. DePasse   +6 more
doaj   +1 more source

Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine

open access: yesFrontiers in Microbiology, 2023
Monkeypox (mpox) is a zoonotic infectious disease caused by the mpox virus. Mpox symptoms are similar to smallpox with less severity and lower mortality.
Nino Rcheulishvili   +7 more
doaj   +1 more source

The role of matrix protein 2 ectodomain in the development of universal influenza vaccines [PDF]

open access: yes, 2019
The influenza A virus matrix protein 2 ectodomain (M2e) is a universal influenza A vaccine candidate. Numerous studies in laboratory mice, but very few in natural influenza A virus hosts, have demonstrated that M2e-based vaccines can provide protection ...
Saelens, Xavier
core   +1 more source

The Pathway to a Universal Influenza Vaccine [PDF]

open access: yesImmunity, 2017
Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.
Paules, Catharine I.   +4 more
openaire   +3 more sources

Subunit Vaccine Targeting Phosphate ABC Transporter ATP-Binding Protein, PstB, Provides Cross-Protection against Streptococcus suis Serotype 2, 7, and 9 in Mice

open access: yesVeterinary Sciences, 2023
Streptococcus suis is a significant pathogen in pigs and a newly emerging zoonotic agent in humans. The presence of multiple serotypes and strains with diversified sequence types in pig herds highlights the need for the identification of broadly cross ...
Zujie Yan   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy